Download our Catalog and Resource Notes
Customer Service or Scientific Support
you need to take your pluripotent stem cell research to the clinic?
Pluripotent stem cells
(PSCs) have the ability to generate the 220+ cell types in the human body.
Because of this unique attribute, these cells have great potential in basic
research, drug discovery and cell replacement therapies.
In 2011, Lonza began
development of a clinical grade master cell bank, uncovering a need for tools
to support working with PSCs in both research and clinical settings. The
ability to streamline your PSC workflow through any stage of research and
development can save you time, effort and money.
Please view the recorded webinar and learn how to maximize your stem cell research efforts.
With Lonza's L7™ hiPSC Reprogramming and hPSC Culture System and Nucleofector™Technology for transfecting non-integrating episomal reprogramming factors, you have solutions for your human PSC workflow at your fingertips.
Speaker: Andrew Winner
Scientific Support Specialist
Lonza Walkersville, Inc.
For further information, please visit www.lonza.com/l7.
View our webinar schedule to not miss any of our upcoming tutorials. Find further previously recorded webinars in our webinar archive.